Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences

Feb 1, 2022 9:15 AM ET

Campaign: Corporate Social Responsibility

What goes into making innovative new medicines? In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.

Originally published by Gilead Sciences

Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences

More from Gilead Sciences

Looking Back to the Future: Gilead’s Long-Standing Commitment To Help End the HIV Epidemic

Gilead Sciences - Born With HIV in the 80s: Kim’s Story of Growing Up as a Dandelion

Gilead Researcher Awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award

Gilead Sciences: Advancing New Ways To Help End the HIV Epidemic Is the Focus of This Installment of “The Centrifuge Sessions”

"The Adventure Jar” - A Children’s Book Supporting Families Impacted by Metastatic Breast Cancer (MBC) Receives Two 2025 Bronze Anvil Awards

Gilead Sciences Commemorated the Opening of the Bay Area Young Survivors Breast Cancer Memorial Garden

Transforming How Cancer Is Treated: Research Results To Be Shared at ASCO25

Gilead Sciences and Kite Pharma To Announce Transformative Cancer Research at This Year’s American Society of Clinical Oncology (ASCO) Annual Meeting